DK1175221T3 - Mælkesyrebakterier med anxiolytiske egenskaber og anvendelser deraf - Google Patents

Mælkesyrebakterier med anxiolytiske egenskaber og anvendelser deraf

Info

Publication number
DK1175221T3
DK1175221T3 DK00925413T DK00925413T DK1175221T3 DK 1175221 T3 DK1175221 T3 DK 1175221T3 DK 00925413 T DK00925413 T DK 00925413T DK 00925413 T DK00925413 T DK 00925413T DK 1175221 T3 DK1175221 T3 DK 1175221T3
Authority
DK
Denmark
Prior art keywords
lactic acid
acid bacteria
anxiolytic properties
anxiolytic
properties
Prior art date
Application number
DK00925413T
Other languages
English (en)
Inventor
Jean-Michel Antoine
Chantal Cayuela
Marie-Christine Degivry
Christian Latge
Eric Postaire
Original Assignee
Gervais Danone Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone Sa filed Critical Gervais Danone Sa
Application granted granted Critical
Publication of DK1175221T3 publication Critical patent/DK1175221T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1238—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using specific L. bulgaricus or S. thermophilus microorganisms; using entrapped or encapsulated yoghurt bacteria; Physical or chemical treatment of L. bulgaricus or S. thermophilus cultures; Fermentation only with L. bulgaricus or only with S. thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00925413T 1999-05-06 2000-05-05 Mælkesyrebakterier med anxiolytiske egenskaber og anvendelser deraf DK1175221T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9905760A FR2793257B1 (fr) 1999-05-06 1999-05-06 Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
PCT/FR2000/001238 WO2000067696A2 (fr) 1999-05-06 2000-05-05 Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations

Publications (1)

Publication Number Publication Date
DK1175221T3 true DK1175221T3 (da) 2007-10-08

Family

ID=9545277

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00925413T DK1175221T3 (da) 1999-05-06 2000-05-05 Mælkesyrebakterier med anxiolytiske egenskaber og anvendelser deraf

Country Status (13)

Country Link
US (1) US6541027B1 (da)
EP (1) EP1175221B1 (da)
JP (1) JP4688298B2 (da)
AT (1) ATE362765T1 (da)
AU (1) AU4414400A (da)
CA (1) CA2373112C (da)
DE (1) DE60034940T2 (da)
DK (1) DK1175221T3 (da)
ES (1) ES2287011T3 (da)
FR (1) FR2793257B1 (da)
MX (1) MXPA01011248A (da)
PT (1) PT1175221E (da)
WO (1) WO2000067696A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444203B2 (en) 1999-12-20 2002-09-03 Compagnie Gervais Danone Administering bacteria to improve sleep
FR2811333B1 (fr) * 2000-07-04 2003-01-10 Gervais Danone Sa Microorganismes ayant une action modulatrice de la glycosylation de surface des cellules intestinales et methode de selection desdits microorganismes
JP3648233B2 (ja) * 2003-04-08 2005-05-18 明治飼糧株式会社 飼料組成物
US20040265279A1 (en) * 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
FR2895877B1 (fr) * 2006-01-06 2012-06-22 Gervais Danone Sa Poudre de lait fermente ou yaourt a haute densite en ferments lactiques
JP5618395B2 (ja) * 2009-08-13 2014-11-05 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
US20130302322A1 (en) 2012-05-11 2013-11-14 Five Prime Therapeutics, Inc. Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r)
MX2015005165A (es) * 2012-10-25 2015-10-29 Gervais Danone Sa Cepas de streptococcus thermophilus para tratar infeccion por helicobacter pylori.
CN105025909B (zh) * 2013-02-27 2020-05-19 株式会社明治 应激减轻剂
JP5853326B2 (ja) * 2013-12-24 2016-02-09 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
ES2929100T3 (es) * 2014-10-28 2022-11-24 Medlab Ip Pty Ltd Tratamiento para la depresión y los trastornos depresivos
KR20180019474A (ko) 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2824821B2 (ja) * 1993-11-04 1998-11-18 カルピス株式会社 乳酸菌及び発酵乳製品
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌

Also Published As

Publication number Publication date
ATE362765T1 (de) 2007-06-15
DE60034940T2 (de) 2008-01-24
US6541027B1 (en) 2003-04-01
DE60034940D1 (de) 2007-07-05
AU4414400A (en) 2000-11-21
ES2287011T3 (es) 2007-12-16
CA2373112A1 (fr) 2000-11-16
FR2793257A1 (fr) 2000-11-10
MXPA01011248A (es) 2002-11-04
JP4688298B2 (ja) 2011-05-25
PT1175221E (pt) 2007-09-04
FR2793257B1 (fr) 2001-07-27
EP1175221B1 (fr) 2007-05-23
WO2000067696A2 (fr) 2000-11-16
JP2002544146A (ja) 2002-12-24
WO2000067696A3 (fr) 2001-03-22
EP1175221A2 (fr) 2002-01-30
CA2373112C (fr) 2012-08-07

Similar Documents

Publication Publication Date Title
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
BRPI0417825A (pt) métodos para uso de lactobacilli probióticos para animais de estimação
NO20016291D0 (no) Kombinasjon av melkesyrebakterier og anvendelse derav for forebyggelse og/eller behandling av infeksjoner og inflammatoriskelidelser
BG105830A (en) C-21 modified epothilones
MY138285A (en) Fab i inhibitors
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
AU300150S (en) Container with product
AU302181S (en) Blower
TW200507841A (en) Antibacterial agents
AU2003291227A8 (en) Antibacterial agents
ATE256131T1 (de) Calanolide zur hemmung von btk
UA82978C2 (ru) ПРОИЗВОДНЫЕ 5-β-САПОГЕНИНА И ПСЕВДОСАПОГЕНИНА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ ДЕМЕНЦИИ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, ПИЩЕВОЙ ПРОДУКТ ИЛИ НАПИТОК НА ИХ ОСНОВЕ
DK1175221T3 (da) Mælkesyrebakterier med anxiolytiske egenskaber og anvendelser deraf
SE9904377D0 (sv) Pharmaceutical combinations
AU2003303956A8 (en) Antibacterial agents
ZA200208262B (en) Inhibition of biological degradation in Fischer-Tropsch products.
DK1157696T3 (da) Behandling af rumen-acidose med alpha-amylaseinhibitorer
ZA200203008B (en) Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis.
ATE348626T1 (de) Milchsäurebakterium zur prävention der bauchfellentzündung
AU300151S (en) Container with product
RU2001135343A (ru) Штамм бактерий Bifidobacterium longum 58B для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
ITMC990052A0 (it) Sistema di predistorsione misto in banda base e if per la linearizzazione di amplificatori.
MXPA03007866A (es) Derivados de fenilo 2.
IT1294369B1 (it) Microorganismi inattivati contenenti minerali, processo per la loro preparazione e loro uso in campo alimentare
ITGE20050022A1 (it) Procedimento ed apparato per la neutralizzazione della carica batterica nei rifiuti solidi ospedalieri od altri prodotti opportunamente triturati, umidificati e caricati in appositi contenitori di sterilizzazione.